L9: Thyrotoxicosis Flashcards
(114 cards)
1
Q
Anatomy of Thyroid Gland
A
2
Q
Histology of Thyroid Gland
A
3
Q
Synthesis of thyroid Hormones
A
4
Q
Forms of thyroid hormone
A
Thyroid hormones circulate in 2 forms:
- Protein bound, mainly thyroxin binding globulin ( TBG ): > 99%
- Free part ( active part ) : less than 1 %
5
Q
Hypothalamic-Pituitary-Thyroid Axis
A
6
Q
Actions of Thyroid Hormones
A
7
Q
Def of Thyrotoxicosis
A
A clinical state that results from any condition leading to high thyroid hormone action in tissues. Irrespective of the source.
8
Q
Def of Hyperthyroidism
A
Form of thyrotoxicosis caused by high synthesis and
secretion of thyroid hormone by the thyroid gland.
9
Q
Characters of Subclinical
hyperthyroidism/thyrotoxicosis
A
- Biochemically as the presence of low thyroid-
stimulating hormone (TSH) and normal free thyroxine
(FT4) and free triiodothyronine (FT3) concentrations. - Patients can be asymptomatic or symptoms of thyrotoxicosis may be present.
10
Q
Characters of Overt primary
thyrotoxicosis
A
- Refers to suppressed TSH with high levels of FT4, FT3, or both.
- Patients can be asymptomatic or more commonly present with symptoms of hyperthyroidism.
11
Q
Def of Thyrotoxic crisis
(thyroid storm)
A
- a life-threatening, acute, and rapid collapse of homeostasis, developing as a result of undiagnosed or inadequately treated thyrotoxicosis and involving altered mental status that may progress to coma, cardiac and multiorgan failure, shock, and death.
12
Q
Etiology of Thyrotoxicosis
A
13
Q
Def of Graveβs Disease
A
14
Q
The most common causes of Thyrotoxicosis
A
ravesβ disease, followed by ο¨ toxic multinodular goiter and toxic adenoma.
15
Q
Incidence of Graveβs Disease
A
- it is the most common cause of hyperthyroidism & occurs at all ages but especially in women of reproductive age
- Peak incidence 20-40 years.
- Female to male incidence 5-8 :1
16
Q
Pathogenesis of Graveβs Disease
A
17
Q
Abs in Graveβs Disease
A
18
Q
Immune Mechanisms in Graveβs Disease
A
Include:
- molecular mimicry and thyroid-cell expression of human leukocyte antigen (HLA) class II molecules (notably HLA-DR).
19
Q
Who is suseptible to Graveβs Disease?
A
Female sex and genetic susceptibility
(cluster in families)
20
Q
What are possible ppt factors for Graveβs Disease?
A
ο Infection
ο Stress- Smoking
ο Pregnancy
ο Iodine and iodine-containing drugs.
21
Q
Mechanism of autoimmunity in Graveβs Disease
A
22
Q
The pathophysiology of GO & pretibial myxedema involves
A
involves the synergism of insulin-like growth factor 1 receptor (IGF1R) with TSHR autoantibodies, causing retro orbital tissue expansion and inflammation.
23
Q
CP of Subclinical Thyrotoxicosis/Hyperthyroidism
A
24
Q
CP of Long-Standing Subclinical Thyrotoxicosis/Hyperthyroidism
A
25
Aspects of CP of **Overt thyrotoxicosis**
Refer to summary
26
General Symptoms
- CP of TTx
Refer to notes ...
27
Neuropsychiatryic Symptoms
- CP of TTx
28
MSK Symptoms
- CP of TTx
29
CVS Symptoms
- CP of TTx
30
Resp Symptoms
- CP of TTx
31
GIT Symptoms
- CP of TTx
32
Reproductive Symptoms
- CP of TTx
33
Renal Symptoms
- CP of TTx
34
Dermatologic Symptoms
- CP of TTx
35
Eye Symptoms
- CP of TTx
36
Metabolic Symptoms
- CP of TTx
37
Bone Symptoms
- CP of TTx
38
Neck Abnormalities
- CP of TTx
39
Autommune Diseases associated with GD
40
Lab Dx of **Graves Disease**
- Thyroid Function Tests
- Thyroid-stimulating antibody (TSab)
- Other lab tests
41
Thyroid Function Tests in **Graves Disease**
42
T3 Toxicosis
T3 level only may be β in some cases (T3 toxicosis)
43
Subclinical hyperthyroidism
low serum TSH concentrations (<0.4 mU/L) but normal serum free T4, and T3
44
TSAB in **Graves Disease**
- Also known as thyroid-stimulating immunoglobulin (TSI), or TSH-receptor antibody (TRAb)
- **Positive test is diagnostic and specific for Gravesβ disease.**
45
Significance of TGB
Serum thyroglobulin TG levels are useful only for excluding thyrotoxicosis caused by exogenous thyroid hormone excess, in which case serum TG is low
46
Other Lab tests of **Graves Disease**
47
Rad investigations for **Graves Disease**
- RAIU
- Thyroid scan (scintigraphy)
- Ultrasonography
- Orbital CT or magnetic resonance imaging (MRI)
- Neck CT
48
RAIU in **Graves Disease**
Measures the percentage of function of the thyroid gland.
- A high (typical of GD or toxic nodule or nodules)
- A low uptake suggests inflammation or destruction of the thyroid gland (such as in thyroiditis)
49
Thyroid Scan in **Graves Disease**
50
US in **Graves Disease**
- of the thyroid gland with assessment of thyroid blood flow also useful to characterize palpable nodules
- Normoechogenic and diffuse large glands, may be enlarged LNs.
- Color flow Doppler shows high blood flow
51
Orbital CT or magnetic resonance imaging (MRI)
- **Graves Disease**
- In patients with Gravesβ orbitopathy ---> an increased volume of extraocular muscles and/or retro bulbar connective tissue
52
Neck CT in **Graves Disease**
only for selected suspicious cases.
53
Cytology in **Graves Disease**
Used to classify thyroid nodules as malignant (thyroid cancer), suspicious, or nonmalignant in order to determine indications for surgery.
54
DDx of **Graves Disease**
55
TTT of **Graves Disease**
A. Medical ( Antithyroid drugs and others )
B. Thyroidectomy
C. Radiotherapy
D. Management of thyrotoxicosis in pregnancy
E. Treatment of complications
56
Members of **Anti-thyroid Drugs**
Methimazole, carbimazole and propylthiouracil (PTU)
57
MOA of **Anti-thyroid Drugs**
ο§ These drugs inhibit the formation of thyroid hormones.
ο§ Propylthiouracil also inhibits conversion of T4 to T3
58
Drug of Choice in GD
Methimazole
59
Dose of Methimazole in GD
β The dose depends on the severity of thyrotoxicosis and varies between 2.5 and 40 mg/day orally.
β Thyroid function tests should be monitored closely and Methimazole tapered to a maintenance dose aiming to achieve euthyroidism.
β In severe hyperthyroidism use up to 60 mg/d orally in 2 to 3 divided doses, and in impending Thyrotoxic crisis, up to 120 mg/d orally or IV (in hospitalized patients).
60
Monitoring of Methimazole
Thyroid function tests should be monitored closely and Methimazole tapered to a maintenance dose aiming to achieve euthyroidism.
61
DOC in GD in pregnancy
propylthiouracil (PTU) is used (in the first trimester)
62
Check up in GD
63
Indications of **Anti-Thyroid Drugs**
1) Mild disease and small goiter because they have high chance of remission
2) Elderly or other comorbidities increasing surgical risk.
3) Limited life expectancy
4) Previous operation or irradiation to the neck
64
CI of **Anti-Thyroid Drugs**
- Huge and retro-sternal goiter.
- Suspicion of malignancy.
65
SE of **Anti-Thyroid Drugs**
66
what are adjuvant medical therapy in GD?
B-Blockers
67
Indicatins of adjuvant medical therapy in GD
* All thyroid patients with resting heart rate >90/min.
* Elderly patients with symptomatic thyrotoxicosis.
68
Classes of adjuvant medical therapy in GD
- Non selective (propranolol in divided doses) Controls both cardiac and psychomotor manifestations.
- Selective B blockers: atenolol 25 to 50 mg daily, once : Control cardiac arrhythmias resulting from hyperthyroidism
69
what are Other adjuvant medical therapy in GD?
- iodine, glucocorticoid, cholestyramine, lithium, and Rituximab.
70
uses of other adjuvant medical therapy in GD
May benefit in patients with severe hyperthyroidism or who are allergic to thionamides.
71
Surgery of Choice in GD
Near-total or total thyroidectomy is the procedure of choice
72
Indications of Surgery in GD
ο Failure of response to anti-thyroid drugs.
ο Severe adverse reactions to anti-thyroid drugs.
ο Patient refuses radioactive iodine treatment.
ο Huge goiter which cause pressure symptoms.
ο Suspected malignancy in thyroid gland.
73
POC for Surgery in GD
ο Anti-thyroid drugs to reduce hyperfunction.
ο Ξ²-blockers to control pulse rate below 80/min.
ο Potassium iodide may be given for 2 weeks before surgery. It reduce intraoperative blood loss.
74
Complications of Surgery in GD
1. Early bleeding, hematoma.
2. Laryngeal nerve palsy occurs in 1%.
3. Transient hypocalcaemia occurs in up to 10% but with Permanent hypoparathyroidism in less than 1%.
4. Recurrent hyperthyroidism
5. Hypothyroidism occurs in about 10% of patients within 1 year, and this percentage increases with time.
6. Complications of general anesthesia.
75
Characters of **RAI in GD**
β Suitable for most patients with Graves' disease.
β It is effective, safe, and does not require hospitalization.
β Given orally in a single dose in a capsule or liquid form.
β Very few side effects as no other tissue absorb RAI.
76
Precautions before **RAI in GD**
Patients with severe hyperthyroidism, elderly patients or patients with underlying heart disease should be pretreated with anti-thyroid drugs and Ξ²- blockers to achieve a euthyroid state prior to radio-active iodine.
77
Indications of **RAI in GD**
1. β Surgical risk due to associated comorbidities.
2. Previous operation or irradiation to the neck.
3. Contraindication for use of anti-thyroid drugs.
4. Recurrence after surgery.
78
Disadvantages of **RAI in GD**
1. Permanent hypothyroidism
2. Rarely radiation thyroiditis
3. Worsening or development of Graves opthalmopathy
4. Patient must take radiation precautions for several days after treatment, avoiding contact with young children and pregnant women.
79
CI of **RAI in GD**
ο Pregnancy and lactation.
ο Children
ο Associated severe opthalmopathy
80
Radioactive TTT of **TTx during Preganncy**
Absolutely contraindicated (teratogenic)
80
TTT of HF
**Complications of GD**
bed rest, salt restriction, digitalis & diuretics.
80
Medical TTT of **TTx during Preganncy**
81
Surgery in **TTx during Preganncy**
- Indicated in women who cannot tolerate side effects of anti-thyroid drugs.
- Surgery can be performed (preferably in the second trimester).
82
TTT of Dermopathy
**Complications of GD**
- Milder cases do not require ttt, for other cases therapy with topical steroids applied under an occlusive plastic dressing film for 3-10 weeks
has been helpful.
83
TTT of Bone Disease due to hyperthyroidism
**Complications of GD**
- Treat hyperthyroidism, give adequate amounts of calcium and vitamin D in diets, typically 1000 to 1200 mg of calcium (total of diet and supplement) and 600 to 800 international units of vitamin D., Only those with highest risk for fracture could benefit from
bisphosphonate therapy
84
what is thyrotoxic Crisis?
- Thyrotoxic crisis is an acute life-threatening exacerbation of thyrotoxicosis in patients who have undiagnosed or inadequately treated thyrotoxicosis and superimposed precipitant factors
- A rare, life-threatening, hypermetabolic condition of severe clinical manifestations of thyrotoxicosis.
85
Physiology of thyrotoxic Crisis
Caused by excessive release of thyroid hormones
86
what percipitates thyrotoxic Crisis?
87
CP of **thyrotoxic Crisis**
88
TTT of **thyrotoxic Crisis**
**Start treatment immediately, without waiting for confirmation by laboratory tests.
Continue treatment at an intensive care unit.**
- Drugs
- Symptomatic
- TTT of Cause
89
Drugs in TTT of **thyrotoxic Crisis**
90
Symptomatic TTT of **thyrotoxic Crisis**
ο Antipyretics : ice bags and acetaminophen
οIV fluids for dehydration
ο Digoxin and diuretics for AF& HF
ο Nasogastric tube for bulbar palsy, nausea and vomiting
91
TTT of Cause of **thyrotoxic Crisis**
antibiotics for infection
92
what are other names of Thyroid eye disease (TED)?
Gravesβs opthalmopathy or Gravesβs
orbitopathy
93
Incidence of **Thyroid eye disease (TED)**
- It is the most common cause of unilateral and bilateral proptosis in adults.
- About 25 to 50% of Grave disease (GD) cases present with thyroid eye disease.
94
Pathology of **Thyroid eye disease (TED)**
- A chronic immunemediated inflammation of the orbit.
- There is an orbital inflammation or infiltration involving the soft tissues, proptosis, and ophthalmoplegia.
95
Etiology of **Thyroid eye disease (TED)**
96
Pathophysiology of **Thyroid eye disease (TED)**
97
CP of **Thyroid eye disease (TED)**
98
Symptoms of **Thyroid eye disease (TED)**
- The patient complains of gritty sensations, photophobia, lacrimation, dry eye, discomfort, and forward protrusion of the eye.
- In more advanced cases, patient may complain eye socket (orbital) pain, double vision, or blurred vision
99
Eye Signs of **Thyroid eye disease (TED)**
100
Dx of **Thyroid eye disease (TED)**
- Exophthalmometer
- Imaging
101
Exophthalmometer
**Dx of Thyroid eye disease (TED)**
Assess the degree of proptosis by
- Measurement of the distance between the lateral angle of the bony orbit and an imaginary line tangent to the most anterior part of the cornea.
- The upper limit of normal is 21 mm in males and 19 mm in females.
102
Imaging
**Dx of Thyroid eye disease (TED)**
103
Managment of **Thyroid eye disease (TED)**
104
Etiology of **Toxic MNG**
- It occurs more commonly in elderly individuals, especially those with a long-standing goiter.
- Caused by hyperplasia of thyroid follicular cells due to activating somatic mutations of the TSH receptor genes.
105
CP of **Toxic MNG**
ο Nodular thyroid enlargement.
ο Manifestations of thyrotoxicosis.
ο No opthalmopathy or dermopathy.
106
Thyroid Scan in **Toxic MNG**
ο Multiple areas of hyperactivity (hot areas)
ο Interspersed with hypoactive regions.
107
TTT of **Toxic MNG**
- Surgery or radioiodine can be used.
- If surgery is chosen, near-total or total thyroidectomy should be performed.
108
Etiology of **Toxic adenoma**
- Caused by a single hyper functioning follicular thyroid adenoma due to mutation in TSH receptor gene.
109
CP of **Toxic adenoma**
ο Solitary thyroid nodule.
ο Manifestations of thyrotoxicosis.
ο No opthalmopathy or dermopathy
110
Thyroid scan of **Toxic adenoma**
- Hyperactive (hot) area,
- the rest of the gland may be hypoactive.
111
TTT of **Toxic adenoma**
- Surgery or radioiodine can be used.
- If surgery is chosen, an ipsilateral thyroid lobectomy or isthmusectomy should be performed
112
Done
..
